IVOZFO DIN 02488094
Status: Approved
Holder: VERITY PHARMACEUTICALS INC.
Health Canada record
| Active ingredient(s) | FOSFOMYCIN (FOSFOMYCIN SODIUM) 8 G |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | J01XX01 FOSFOMYCIN |
|---|
| Original market date | |
|---|
| Current status date | 01-May-2019 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Verity Pharmaceuticals Inc. — licence 3-002542, currently licensed, last inspection rating C (2023-12-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FOSFOMYCIN (FOSFOMYCIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02488078 | IVOZFO | VERITY PHARMACEUTICALS INC. | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN SODIUM) 2 G | Approved |
| 02488086 | IVOZFO | VERITY PHARMACEUTICALS INC. | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN SODIUM) 4 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 22103 | 2019-05-01 | New Drug Submission (NDS) | |
Request a quote for IVOZFO
How to read a Canadian DIN record